In this study, we verified that GBM cells preferentially express anti-apoptotic Bcl-xL through splicing at the proximal 5′ splice site (5’PSS) of exon 2 of BCLX pre-mRNA. This evidence concerns the gene BCL2L1 and glioblastoma.